{
    "title": "Shionogi says COVID pill trial shows reduction in symptoms",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11257313/Japans-Shionogi-says-COVID-pill-reaches-Phase-III-milestone.html",
    "date": "2022-09-28",
    "keywords": [
        "drug",
        "covid19",
        "phase",
        "trial",
        "company",
        "approval",
        "co",
        "japan",
        "inc",
        "government",
        "tokyo",
        "ltd",
        "wednesday",
        "treatment",
        "reduction",
        "placebo",
        "asia",
        "protease",
        "inhibitor",
        "endpoint",
        "statement",
        "shionogis",
        "decline",
        "announcement",
        "versus",
        "drop",
        "benchmark",
        "gauge",
        "ensitrelvir",
        "goal",
        "omicron",
        "variant",
        "emergency",
        "use",
        "pill",
        "effectiveness",
        "risk",
        "iii",
        "study",
        "part",
        "shionogi",
        "s217622",
        "brand",
        "name",
        "pfizer",
        "merck",
        "agreement",
        "chief",
        "executive",
        "isao",
        "teshirogi",
        "production",
        "firm",
        "support",
        "reporting",
        "swift",
        "christopher",
        "pullin",
        "angus",
        "macswan"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}